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Introduction: It is estimated that incidence of urinary tract infec-
tions (UTI) in a whole world is ~150 million per year. In Health 
center Novi Sad (out hospital care), UTIs are after respiratory tract 
infections most common reason for prescribing antibiotics. Usual 
practice is empiric treatment of UTIs, while urine analysis is done 
in case of empiric treatment failure, recurrent or complicated UTIs. 
Most common pathogen in UTIs is Escherichia coli. The aim of the 
study was to analyze prescribing habits, compliance of prescribing 
with national guidelines, and local resistance of isolated bacteria.
Patients (or Materials) and Methods: Novi Sad Health center offers 
health services to a population of ~385,000 inhabitants. Study was 
done in period from January – December 2012. Data on drug pre-
scribing and most common bacteria isolated from urine samples were 
collected, analyzed, and compared with national guidelines on treat-
ment of UTIs.
Results: Of about 20,000 urine samples analyzed, ~30% were 
positive. The most common bacteria isolated were E coli (~70%), 
Proteus mirabilis, Klebsiella pneumoniae, and Enterococcus species, 
all 3 with ~8% incidence. There were ~40,000 prescriptions for the 
treatment of UTIs. Most frequently prescribed drug was cefalexine 
(~30%), followed by ciprofloxacin (~25%), pipemidic acid (~13%), 
co-trimoxazole (~11%), and amoxicilline + clavulic acid (~4%).
Conclusion: Deviations in prescribing habits regarding the national 
guidelines include: (1) most frequently prescribed drug is cefalexine, 
recommended only in case of allergy to sulpha-derivates, and if fluo-
roquinolones are contraindicated; additional problem is decreased 
sensitivity to cefalexine in most frequently isolated bacteria E coli, 
61.75%; P mirabilis, 52.69%; K pneumonia, 47.44%; (2) although 
the resistance of E coli to co-trimoxazole is > 20% (32%), it is still 
prescribed for treatment of UTIs (11% of all prescriptions; and (3) 
other isolated bacteria, except E coli, have sensitivity of ≤50% to 
most of the recommended drugs. These data indicate that there exists 
a necessity to harmonize national guidelines with local resistance of 
bacteria. After harmonization, medical doctors should be instructed 
to follow the national guidelines in order to control bacterial resist-
ance and assure positive therapeutic outcome.
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Introduction: Alzheimer’s disease (AD) is a progressive disorder in 
which brain cells (neurons) deteriorate, resulting in the loss of cog-
nitive functions, primary memory, judgment, reasoning, movement 
coordination, and pattern recognition. This study was designed to 
investigate the effect of α -chymotrypcin (α -ch) on management of 
AD in an experimental model.
Patients (or Materials) and Methods: Sixty adult female albino rats 
were divided into 4 groups each of 15 rats: (1) normal control rats 
(con group); (2) rats underwent surgery to remove ovaries (Ovx 
group); (3) ovariectomized group received aluminum chloride in 
a dose of 17 mg/kg daily, orally for 2 months, to induce AD (AD 
group); and (4) AD group treated with α -chymotrypcin at dose (8.1 
unit/rat/d IM) for 3 months (α -ch). At the end of the experimental 
period, rats were sacrificed; brain samples were obtained for dif-
ferent biochemical analyses and histopathologic examination. The 
biochemical analyses included determination of transforming growth 
factor-β (TGF-β ), brain-derived neurotrophic factor (BDNF), and 
vascular endothelial growth factor (VEGF).
Results: In comparison with the normal control group, the Ovx 
group recorded significant increase in the brain level of TGF-β , while 
the brain levels of BDNF and VEGF were significantly decreased. 
Similarly, AD group recorded significant increase in the brain level 
of TGF-β accompanied with significant decrease in brain BDNF and 
VEGF levels compared with the Ovx group. However, the treatment 
of the AD group with α -chymotrypcin resulted in an improvement in 
the biochemical parameters which reflected by decreased brain level 
of TGF-β accompanied with a significant increase in the brain levels 
of BDNF and VEGF, compared with AD group. Histopathologic 
investigation of brain tissue of Ovx rats administered with aluminum 
showed AD plaques indicating the validation of AD model. While, 
AD group treated with α -chymotrypcin showed great improvement 
in the brain morphological structure and disappearance of most of 
amyloid plaques.
Conclusion: This study revealed that the treatment of AD rats with 
α -chymotrypcin significantly ameliorates the neurodegeneration as 
well as modulates the essential growth factor in the brain of AD 
model due to its proteolytic activity, anti-inflammatory effect, and 
antioxidant capacity.
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Introduction: Large observational studies in patients with type 2 
diabetes mellitus (DM) have demonstrated that metformin treatment 
improves cardiovascular prognosis, independent of glycemic control. 
Subsequent animal studies, both in animals with and without DM, 
have indeed shown that metformin has direct acute cardioprotective 
effects. Whether metformin also limits ischemia-reperfusion (IR)-
injury in humans is currently unknown. Therefore, in this study, we 
examined whether metformin treatment limits IR injury in a forearm 
model of endothelial IR-injury in healthy middle-aged volunteers.
Patients (or Materials) and Methods: Twenty-six healthy volunteers 
(age, 41 [6] years; 10 male/16 female), were randomized between 
pretreatment with metformin 500 mg 3 times a day for 3 days or no 
medication in a randomized crossover trial with a washout period 
of 2 weeks. Brachial artery flow-mediated dilation (FMD) was meas-
ured using high-resolution Doppler ultrasound before and after 20 
minutes of forearm ischemia and 20 minutes of reperfusion. Brachial 
